Research News and Research

RSS

Metabolic Solutions to present MSDC-0160 clinical candidate data at EASD conference

Metabolic Solutions Development Company (MSDC), will present research at the European Association for the Study of Diabetes (EASD) annual conference in Stockholm, Sweden on Sept. 23, 2010. The research indicates that the company's clinical candidate, MSDC-0160, promotes the proliferation of stem cells that create brown fat, leading to the creation of more brown fat. The research was conducted in tissue cultures and mice.

17 Sep 2010

Myrexis to present poster on cancer metabolism inhibitor program

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will present a poster at the Cancer and Metabolism: Pathways to the Future meeting in Edinburgh, Scotland, as well as two additional posters at the 22nd European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR) Symposium on "Molecular Targets and Cancer Therapeutics" November 16-19, 2010, in Berlin, Germany.

17 Sep 2010

Poorer patients wait months for basic services in Minn.; Calif. unions criticize plan for state workers to pay more for benefits; Neb. Medicaid study questioned

Minnesota Public Radio: "Three months after the state implemented a scaled-back health care coverage program for its poorest residents, many patients are waiting months for basic medical services and hospitals have lost millions of dollars in uncompensated care. … The restructuring of the General Assistance Medical Care (GAMC) program has forced thousands of low-income residents … to leave their medical providers and receive care through one of four Twin Cities-area hospitals.

17 Sep 2010

Researchers decode key DNA in evolution of aging, development and fertility

UC Irvine researchers have deciphered how lowly fruit flies bred to rapidly develop and reproduce actually evolve over time. The findings, reported in the Sept. 15 online issue of Nature, contradict the long-held belief that sexual beings evolve the same way simpler organisms do and could fundamentally alter the direction of genetic research for new pharmaceuticals and other products.

17 Sep 2010

Media outlets examine how maternal health, efforts to reduce global poverty will be central to next week's MDG Summit

Media outlets continued to look ahead to next week's U.N. Millennium Development Goal (MDG) Summit, with a focus on two of the central themes to be addressed at the meeting - maternal health and poverty.

17 Sep 2010

Study identifies venous thromboembolism risk factors after THR surgery

Risk factors for venous thromboembolism after total hip replacement (THR) surgery were identified in a new study published in the September 2010 issue of The Journal of Bone and Joint Surgery (JBJS). While the rate of thromboembolism has been significantly reduced through medication, understanding the risk factors could further reduce the likelihood of patients developing this potentially fatal complication.

17 Sep 2010

New imaging technique visualizes myocardial scar and heart's blood vessels simultaneously

Cardiologists and surgeons may soon have a new tool to improve outcomes for patients requiring pacemakers, bypass surgery or angioplasties. Research led by Dr. James White and his colleagues at The University of Western Ontario has led to a new imaging technique, which provides a single, 3D high-resolution image of the heart revealing both its vasculature and the presence of scar tissue within the muscle.

17 Sep 2010

Common Alzheimer's disease drug enhances learning of new skills

Research on a drug commonly prescribed to Alzheimer's disease patients is helping neuroscientists at the University of California, Berkeley, better understand perceptual learning in healthy adults.

17 Sep 2010

Researchers reveal Prozac reactions to increase serotonin level

The response time to antidepressants, such as Prozac, is around three weeks. The adaptation mechanisms of the neurons to antidepressants has, until now, remained enigmatic. In particular, the researchers have revealed, for the first time, a sequence of reactions caused by Prozac at the neuron level, which contributes to an increase in the amounts of serotonin, a chemical "messenger" essential to the brain, and deficient in depressive individuals.

17 Sep 2010

Democratic candidates spend more on ads against than for health reform

Politico: Democratic candidates are spending three times more — nearly $1 million — in advertising against health reform than for it. "Since the beginning of Congress's August recess, Democratic candidates have poured $930,000 into ads deriding the health overhaul but just $300,000 in pro-reform spots, according to Evan Tracey at Kantar Media."

17 Sep 2010

Scientists discover new drug target to improve radiation effectiveness for treating cancer

Scientists at Washington University School of Medicine in St. Louis have discovered a new drug target that could improve the effectiveness of radiation for hard-to-treat cancers.

17 Sep 2010

Researchers suggest DASH-style diet reduces kidney stone formation

Certain key ingredients of a diet designed to prevent high blood pressure can ward off kidney stones, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest how low-fat dairy products and/or plants may have potent kidney stone-fighting properties.

17 Sep 2010

New anti-pathogenic drugs render MRSA harmless without killing bacteria

Menachem Shoham, PhD, associate professor and researcher in the department of biochemistry at the Case Western Reserve University School of Medicine, has identified new anti-pathogenic drugs that, without killing the bacteria, render Methicillin Resistant Staphylococcus Aureus (MRSA) harmless by preventing the production of toxins that cause disease.

17 Sep 2010

Waxman says controversial Medicare bidding program for medical equipment should proceed

CQ HealthBeat: "House Energy and Commerce Chairman Henry A. Waxman said Wednesday that a controversial Medicare bidding program that would cut the costs of medical equipment such as wheelchairs and oxygen supplies should go forward under tight scrutiny. Waxman said ... he takes seriously the concerns of suppliers and some patients' groups that service and access to supplies could be undermined by the money-saving program, but said there is no evidence so far of that happening based on limited early tests of the approach."

17 Sep 2010

ResMed's new CPAP device increases patients' compliance with sleep therapy

ResMed, a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment today announced the results of a clinical study confirming that patients' compliance with sleep therapy increases when using ResMed's new CPAP device.

From ResMed Corp 17 Sep 2010

Defensive medicine costs U.S. healthcare system $45 billion

Lisa Maas, executive director of Californians Allied for Patient Protection (CAPP), issued the following statement in response to a recent study published in the 2010 issue of Health Affairs which found that costs related to medical liability account for more than $55 billion a year or 2.4% of the total costs to the U.S. healthcare system. According to the study, approximately 80%, or $45 billion of these costs are the result of defensive medicine, procedures performed to avoid unnecessary litigation.

17 Sep 2010